• Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

15 Questions That Reveal If You’re the Problem at Work

March 20, 2026

Don’t Let New Regulations Overwhelm You — Take Control in 30 Days or Less

March 20, 2026

How to Spot High-Potential Employees in Their First 30 Days on Your Team

March 20, 2026
Facebook Twitter Instagram
Trending
  • 15 Questions That Reveal If You’re the Problem at Work
  • Don’t Let New Regulations Overwhelm You — Take Control in 30 Days or Less
  • How to Spot High-Potential Employees in Their First 30 Days on Your Team
  • 5 Ways to Survive the Coming Medicare Premium Shock
  • Forget the 1%. These CEOs Are in the 0.001% — and the Numbers Will Make Your Head Spin
  • One Upgrade All Franchises Need to Survive Peak-Hour Pressure
  • What Every CEO Should Do When a Customer Claims Your Business Caused Harm
  • How Welcoming Disagreement Makes You a Better Leader
Friday, March 20
Facebook Twitter Instagram
Indenta
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
Indenta
Home » Stocks making the biggest moves premarket: Warby Parker, HP, Point Biopharma and more
News

Stocks making the biggest moves premarket: Warby Parker, HP, Point Biopharma and more

News RoomBy News RoomOctober 3, 20239 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

Check out the companies making headlines before the bell.

Warby Parker — Warby Parker jumped about 4% after Evercore ISI upgraded the eyeglass retailer to an outperform rating, saying that shares could rally more than 50% as the company’s margins and revenue growth reaccelerate.

Eli Lilly, Point Biopharma — Shares of Point Biopharma popped 85% after Eli Lilly announced it would buy the cancer therapy maker for $12.50 in cash, or roughly $1.4 billion.

HP — Shares added 2.5% after being double upgraded by Bank of America to buy from underperform. The bank expects improving fundamentals for the PC maker, with free cash flow hitting a bottom in 2023.

McCormick— Shares of the spice maker slipped about 3% before the bell. McCormick reported earnings of 65 cents per share, excluding items, for the recent quarter on revenues of $1.68 billion. That came in roughly in line with the EPS of 65 cents and $1.7 billion in revenue expected by analysts polled by StreetAccount.

Warner Music Group — Warner added 3.5% after UBS upgraded the stock to buy from neutral. UBS said the company should be a long-term beneficiary of trends in the music industry. 

Airbnb — Airbnb shares slipped 3% in the premarket after KeyBanc Capital Markets downgraded the short-term home-rental stock as tailwinds from the post-pandemic boom in travel demand ease.

Fiverr International — Shares gained 2.8% after Roth MKM upgraded the Fiverr International to buy from neutral. The Wall Street firm is “incremental positive” on the stock, citing a freelancer survey that supports Fiverr’s leading position among gig workers.

Emerson Electric — The industrial giant dipped 1% in premarket trading after UBS downgraded the stock to neutral from buy, citing the company’s valuation and limited upside. The firm increased its price target, however.

— CNBC’s Alex Harring, Sarah Min, Michelle Fox and Pia Singh contributed reporting

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

RSS Feed Generator, Create RSS feeds from URL

News November 1, 2024

X CEO Linda Yaccarino addresses Musk’s ‘go f—- yourself’ comment to advertisers

News November 30, 2023

67-year-old who left the U.S. for Mexico: I’m happily retired—but I ‘really regret’ doing these 3 things in my 20s

News November 30, 2023

U.S. GDP grew at a 5.2% rate in the third quarter, even stronger than first indicated

News November 29, 2023

Americans are ‘doom spending’ — here’s why that’s a problem

News November 29, 2023

Jim Cramer’s top 10 things to watch in the stock market Tuesday

News November 28, 2023
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

Don’t Let New Regulations Overwhelm You — Take Control in 30 Days or Less

March 20, 20260 Views

How to Spot High-Potential Employees in Their First 30 Days on Your Team

March 20, 20260 Views

5 Ways to Survive the Coming Medicare Premium Shock

March 19, 20260 Views

Forget the 1%. These CEOs Are in the 0.001% — and the Numbers Will Make Your Head Spin

March 19, 20261 Views
Don't Miss

One Upgrade All Franchises Need to Survive Peak-Hour Pressure

By News RoomMarch 19, 2026

Entrepreneur Key Takeaways Peak-hour failures expose infrastructure weaknesses that quietly cap revenue and customer conversion.…

What Every CEO Should Do When a Customer Claims Your Business Caused Harm

March 19, 2026

How Welcoming Disagreement Makes You a Better Leader

March 19, 2026

The Hidden Growth Bottleneck Most Founders Don’t See

March 19, 2026
About Us

Your number 1 source for the latest finance, making money, saving money and budgeting. follow us now to get the news that matters to you.

We're accepting new partnerships right now.

Email Us: [email protected]

Our Picks

15 Questions That Reveal If You’re the Problem at Work

March 20, 2026

Don’t Let New Regulations Overwhelm You — Take Control in 30 Days or Less

March 20, 2026

How to Spot High-Potential Employees in Their First 30 Days on Your Team

March 20, 2026
Most Popular

Australia stocks lower at close of trade; S&P/ASX 200 down 0.13%

November 17, 20233 Views

Key Fed inflation gauge rose 0.3% as expected in September; spending tops estimate

October 27, 20233 Views

Earnings call: Exponent Reports Q3 Growth, Forecasts Mid-Single-Digit Revenue Growth for Q4

October 27, 20233 Views
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2026 Inodebta. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.